|
|
|
|
|
|
|
By Julio G. Martinez-Clark, bioaccess
|
For years, Chile has been a comparatively easy to enter market for the medtech industry. That era now has an expiration date. High-risk, technically complex products will be the most affected by a new decree.
|
|
|
|
|
|
|
|
|
|
De-Risk Your Combination Product Development
|
|
Infographic | West Pharmaceutical Services, Inc.
|
Adopting a unified, pre-verified drug delivery system streamlines performance testing and data management, ensuring developers reach critical clinical milestones with greater speed.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Connect With Med Device Online: |
|
|
|
|